AzTrials
AzTrials

Parent-Child RelationsPhase 1SPACESNCT05919849

Supporting Parents in Affirming Their Children's Experiences of Stigma

A Phase 1 study testing Brief online writing intervention in people with Parent-Child Relations, run by Yale University at 4 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to develop and test two brief online writing interventions to improve parental acceptance of sexual and gender minority youth (SGMY) in the Southeast United States. Read more about this study

Who is it for?
Ages 15 years and older
Conditions the study is for
Parent-Child Relations
What is being tested?
Brief online writing intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
132 participants
Where
4 sitesin 2 countries
Study dates
29 Nov 2023to 12 May 2026
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Parents are eligible if they meet the following criteria:
  • Be a parent, grandparent, or any other family member who considers themselves a guardian of an SGMY between 15-29 years old,
  • Live in the Southeast United States (Louisiana, Mississippi, Alabama, Georgia, South Carolina, North Carolina, Tennessee, Arkansas, Kentucky, Florida),
  • Identify as heterosexual and cisgender, and
  • Report non-acceptance of their SGMY.
  • SGMY are eligible if they meet the following criteria:
Show all 10Show fewer
  • Self-identify as SGM,
  • Are 15-29 years old,
  • Live in the Southeast United States, and
  • Have a parent enrolled in the trial

Who cannot join

  • Any individual who meets any of the following criteria will be excluded from participation in this study:
  • Active mania, psychosis, or suicidality, and
  • Unable to provide informed consent.

Trial locations and contacts

4 sites in 2 countries.

4 sites in 2 countries

United States3 sites
  • University of Maryland

    College Park, Maryland, 20742

  • Vanderbilt University

    Nashville, Tennessee, 37235

  • Yale University

    New Haven, Connecticut, 06510

Other trials in United States

Israel1 site
  • Ben-Gurion University

    Beersheba, 84105

Other trials in Israel

About this study

Official title: Development and Initial Trial of Two Brief Interventions to Support Parents in Affirming Their Children's Experiences of Sexuality and Gender

The purpose of this study is to develop and test two brief online writing interventions to improve parental acceptance of sexual and gender minority youth (SGMY) in the Southeast United States.

Read the detailed description

The purpose of this study is to develop and test the acceptability, feasibility, and preliminary efficacy of two brief online writing interventions to improve parental acceptance of sexual and gender minority youth (SGMY) in the Southeast United States. Parental support represents the strongest predictor of sexual and gender minority youth's (SGMY) mental health. However, many parents react to their SGMY's disclosure with rejection. Even relatively accepting parents can experience discomfort, while SGMY often report lingering unmet needs from their parents into adulthood. Few interventions exist to help parents support their SGMY child and none has been tested in a randomized trial with efficacy for decreasing parental rejection and increasing support of their SGMY. This proposal will develop and test the efficacy of two theory-based interventions that aim to address this gap. Results will identify mechanisms contributing to parental rejection and develop scalable approaches to reduce these mechanisms to shrink the substantial mental health disparities affecting SGMY. If efficacious, these interventions can be scaled up through online platforms capable of bypassing barriers to parental support of SGMY across high-stigma regions.

The focus of this registration is the randomized controlled trial.

Being tested
Brief online writing intervention, Control condition
Keywords
Parental Acceptance, Sexual and Gender Minority Youth
Medical subject headings
Coitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Brief online writing interventionBehavioural

    Participants will be instructed to write for 20 minutes across 3 consecutive days. They will be writing based on the prompts given to them.

  • Control conditionOther

    Participants will be instructed to write in order to control for time and writing engagement.

Study groups in NCT05919849
Study groupRoleWhat they receive
Expressive Writing (EW)ExperimentalParticipants in the expressive writing (EW) condition will be instructed to write in a free-form manner about the most stressful aspects of being a parent of an SGMY, following standard EW procedures.
Receives: Behavioral: Brief online writing intervention
Attachment-Based Writing (ABW)ExperimentalParticipants in the attachment-based writing (ABW) condition will respond to distinct prompts created for the condition based on components of attachment-based family therapy (ABFT).
Receives: Behavioral: Brief online writing intervention
Neutral Writing (Control)OtherParticipants in the control condition will be asked to write about what they have done since waking up that morning.
Receives: Other: Control condition

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Parents' Rejecting and Supportive Behaviors Measured By the Parent Non-Acceptance Scale

    The 10-item Parent Non-Acceptance Scale is a self-reported instrument assessing positive and negative indicators of parental acceptance of their SGMY. Parents report level of agreement on a scale from 1 (Strongly Disagree) to 6 (Strongly Agree), with a higher score on negative indicators representing a higher level of non-acceptance and a higher score on positive indicators representing a lower level of non-acceptance.

    Measured: Baseline, 5 Days Post-Baseline, and 3 Months Post-Baseline

Secondary outcomes (18)
  1. Change in Secondary Parental Acceptance and Rejection Measured By the Children's Report of Parent Behavior Inventory

    The Children's Report of Parent Behavior Inventory (CRPBI) is a 10-item rejection/support subscale assessing level of rejection/support. Parents report how much each statement describes the way they acted towards their SGMY ranging from 1 (not like you) to 3 (a lot like you), where Acceptance and Psychological Control scores are the totals of the individual items in the respective sub-scales, and Firm Control score is obtained by taking the sum of the Firm Control + subscale, adding 24, and by then subtracting the total of the Firm Control -- subscale.

    Measured: Baseline, 5 Days Post-Baseline, and 3 Months Post-Baseline

  2. Change in Secondary Parental Acceptance and Rejection Measured By the the Parental Acceptance/Rejection Questionnaire

    The 24-item Parental Acceptance/Rejection Questionnaire describes the way parents act towards their children. Parents report how true each statement is on a scale from 1 (almost always true of me) to 4 (almost never true of me) where a higher score indicates a higher level of rejection.

    Measured: Baseline, 5 Days Post-Baseline, and 3 Months Post-Baseline

  3. Change in Secondary Parental Acceptance and Rejection Measured By the Five-Minute Speech Sample

    The Five-Minute Speech Sample (FMSS) is a measure of parent-child dynamics where parents talk for 5 minutes about their thoughts and feelings about their SGMY. The qualitative interview is coded and scored appropriately to measure parental behavior towards their SGMY

    Measured: Baseline, 5 Days Post-Baseline, and 3 Months Post-Baseline

  4. Change in Parent-Child Relationship Quality and Stress Assessed by the Parental Environment Questionnaire Conflict, Involvement, and Regard for Child Subscales

    The Parental Environment Questionnaire Conflict (12-item), Involvement (12-item), and Regard for Child (5-item) Subscales assess perceptions of parent-child relationship quality. Parents rate how true each statement is on a scale from 1 (definitely true) to 5 (definitely false), where a high score on the conflict scale indicates greater parental conflict, a high score on the involvement scale indicates less parental involvement, and a high score on the regard for child scale indicates high regard for child.

    Measured: Baseline, 5 Days Post-Baseline, and 3 Months Post-Baseline

  5. Change in Parent-Child Relationship Quality and Stress Assessed by the McMaster Family Assessment Device General Functioning Subscale

    The 12-item McMaster Family Assessment Device General Functioning Subscale further assesses perceived parent-child relationship quality and stress on a scale of "strongly agree" (1) to "strongly disagree" (4), where a higher score indicates lower general family functioning.

    Measured: Baseline, 5 Days Post-Baseline, and 3 Months Post-Baseline

  6. Change in Parent Anti-SGM Bias Assessed Using the Social Distance Scale

    The Social Distance Scale assesses anti-LGBTQ (Lesbian, Gay, Bisexual, Trans, Queer) stigma by assessing parents' responses to different scenarios from 0 (definitely unwilling or completely uncomfortable) to 3 (definitely willing or completely comfortable), where a lower score indicates stronger anti-LGBTQ stigma.

    Measured: Baseline, 5 Days Post-Baseline, and 3 Months Post-Baseline

  7. Change in Parent Anti-SGM Bias Assessed Using the Lesbian, Gay, Bisexual Affiliate Stigma Measure

    The Lesbian, Gay, Bisexual Affiliate Stigma Measure (LGB-ASM) measures affiliate stigma faced by heterosexual family and friends of sexual minority people. Parents rate how much they agree with each statement on a scale from 1 (strongly disagree) to 6 (strongly agree), with the option to claim "not applicable." A higher score indicates stronger affiliate stigma.

    Measured: Baseline, 5 Days Post-Baseline, and 3 Months Post-Baseline

  8. Change in Parent-Child Unresolved Conflict Measured Using the Unfinished Business Scale

    The 11-item Unfinished Business Scale was adapted by Principal Investigator Pachankis with strong psychometric properties to measure parents' unresolved negative thoughts and feelings towards their SGMY. Parents rate statements about their SGM child on a scale from 1 (not at all) to 5 (very much), where a higher score represents greater unresolved parent-child conflict.

    Measured: Baseline, 5 Days Post-Baseline, and 3 Months Post-Baseline

  9. Change in Parent Depression and Anxiety Using the PROMIS (Patient-Reported Outcomes Measurement Information System®) Depression, Anxiety, and Anger Scales

    The 63-item PROMIS Depression, Anxiety, and Anger questionnaires measure parent-reported frequency of depression, anxiety, and anger symptoms over the past 7 days on a scale from 1 (never) to 5 (always), where higher scores indicate higher severity of symptoms.

    Measured: Baseline, 5 Days Post-Baseline, and 3 Months Post-Baseline

  10. Change in Parent Perceived Stress Using the Perceived Stress Scale

    The 10-item Perceived Stress Scale assesses parents' perceived stress by asking about frequency of thoughts and feelings during the past month on a scale from 0 (never) to 4 (very often), where a higher score indicates a higher level of perceived stress.

    Measured: Baseline, 5 Days Post-Baseline, and 3 Months Post-Baseline

  11. Change in Parent Report of Child Depression and Anxiety Using the PROMIS Depression and Anxiety Scales

    The 15-item proxy-report PROMIS Depression and Anxiety Scales measures parent report of their SGM child's depression and anxiety symptoms by asking frequency of the SGMY's symptoms over the past 7 days on a scale from 1 (never) to 5 (always), where higher scores indicate a greater severity of parent-reported symptoms.

    Measured: Baseline, 5 Days Post-Baseline, and 3 Months Post-Baseline

  12. Change in Parent Negative Emotion Using a Modified Positive and Negative Affect Schedule (PANAS)

    The 20-item Positive and Negative Affect Schedule (PANAS) inquires about parents' positive and negative affect towards their SGMY. Participants indicate how often they have felt either positive or negative indicators on a scale of 1 (very slightly or not at all) to 5 (extremely). A high score on positive affect indicators indicates a higher positive affect towards the SGMY, while a high score on negative affect indicates a higher negative affect towards the SGMY.

    Measured: Baseline, 5 Days Post-Baseline, and 3 Months Post-Baseline

  13. Change in Parent Empathy Measured By the Questionnaire of Cognitive and Affective Empathy

    The 31-item Questionnaire of Cognitive and Affective Empathy (QCAE) measures parent empathy toward their SGMY. Parents rate how much a statement relates to them on a scale of 1 (strongly disagree) to 4 (strongly agree), where a high score indicates a high level of empathy toward the SGMY.

    Measured: Baseline, 5 Days Post-Baseline, and 3 Months Post-Baseline

  14. Intervention Acceptability Measured By the Client Satisfaction Questionnaire

    The Client Satisfaction Questionnaire is an 8-item measurement of perceived helpfulness, likelihood of recommending, and positive experience. Participants rate statements on a scale of 1 (most negative) to 4 (most positive), with a high score representing a higher level of satisfaction.

    Measured: 3-Month-Post-Baseline

  15. Intervention Acceptability Measured By the Treatment Acceptability Survey

    The 17-item Treatment Acceptability Survey assesses perceived helpfulness, likelihood of recommending, and positive experience of the interventions. Participants rate statements on a scale of 1(strongly disagree) to 4 (strongly agree), with a higher score representing a higher level of acceptability.

    Measured: 3-Month-Post-Baseline

  16. Intervention Feasibility Measured By Percentage of Intervention Sessions Completed

    Intervention feasibility will be partially measured by the percentage of intervention sessions participants complete.

    Measured: Measured Throughout Intervention (Up to 2 Weeks)

  17. Intervention Feasibility Measured By Percentage of Fully Engaged Sessions

    Intervention feasibility will be partially measured by the percentage of fully engaged sessions, defined as the number of writing sessions that included at least 313 words.

    Measured: Measured Throughout Intervention (Up to 2 Weeks)

  18. Intervention Feasibility Measured By Number of Platform Technical/Accessibility Issues

    Intervention feasibility will partially be tracked by the number of platform technical or accessibility issues noted throughout the intervention.

    Measured: Measured Throughout Intervention (Up to 2 Weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jun 2023
  2. Study start29 Nov 2023
  3. Primary completion12 May 2026
  4. Study completion12 May 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study is a 3-arm randomized control trial (RCT) design in which an anticipated129 parents of SGMY will be randomized into one of three conditions.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
132 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05919849
Sponsor's protocol ID
2000035266
Other IDs
1R21HD110617-01A1
Acronym
SPACES
Status last verified
Sep 2026
First submitted
16 Jun 2023
Last updated
2 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Aggregated baseline and follow-up data will be uploaded to the National Institute of Mental Health Data Archive (NDA) following the conclusion of the study. All participants will be informed of the study's confidential data sharing procedures at the time of consent. Given the personal and sensitive nature of data contained in the intervention writing samples, qualitative interviews, and the 5-minute speech task, these data will be uploaded in aggregate. De-identified individual participant data (IPD) (i.e., questionnaires, data dictionaries) generated with funds from this grant will be freely distributed, as available, to qualified academic investigators for non-commercial research. The study investigators as well as their institutions will adhere to the NIH Grants Policy on Sharing of Unique Research Resources including the "Sharing of Biomedical Research Resources: Principles and Guidelines for Recipients of NIH Grants and Contracts" issued in 2003.

Publications

  • Clark, K. A., Dougherty, L. R., & Pachankis, J. E. (2021). A study of parents of sexual and gender minority children: Linking parental reactions with child mental health. Psychology of Sexual Orientation and Gender Diversity, Advance online publication.

  • Schludermann E, Schludermann S. Children's Report on Parent Behavior (CRPBI-108, CRPBI-30) Winnipeg, Canada: Unpublished manuscript, Department of Psychology, University of Manitoba; 1988.

  • Rohner, R. P. (2005). Parental acceptance-rejection/control questionnaire (PARQ/Control): Test manual. In R. P. Rohner & A. Khaleque (Eds.), Handbook for the study of parental acceptance and rejection (4th ed., pp. 137-186). Rohner Research Publications.

  • Weston, S., Hawes, D. J., & S Pasalich, D. (2017). The five-minute speech sample as a measure of parent-child dynamics: Evidence from observational research. Journal of Child and Family Studies, 26(1), 118-136. https://doi.org/10.1007/s10826-016-0549-8

  • Elkins IJ, McGue M, Iacono WG. Genetic and environmental influences on parent-son relationships: evidence for increasing genetic influence during adolescence. Dev Psychol. 1997 Mar;33(2):351-63. doi: 10.1037//0012-1649.33.2.351.

    PubMed 9147842
  • Epstein, N. B., Baldwin, L. M., & Bishop, D. S. (1983). The McMaster Family Assessment Device. Journal of Marital and Family Therapy. Vol 9 (2) 171-180. https://doi.org/10.1111/j.1752-0606.1983.tb01497.x

  • Link, B. G., Cullen, F. T., Frank, J., & Wozniak, J. F. (1987). The social rejection of former mental patients: Understanding why labels matter. American Journal of Sociology, 6, 1461-1500.

  • Robinson MA, Brewster ME. Understanding affiliate stigma faced by heterosexual family and friends of LGB people: A measurement development study. J Fam Psychol. 2016 Apr;30(3):353-63. doi: 10.1037/fam0000153. Epub 2015 Sep 28.

    PubMed 26414416
  • Singh, M. (1994). Validation of a measure of session outcome in the resolution of unfinished business. Unpublished doctoral dissertation, York University, Toronto, Ontario, Canada

  • Schalet BD, Pilkonis PA, Yu L, Dodds N, Johnston KL, Yount S, Riley W, Cella D. Clinical validity of PROMIS Depression, Anxiety, and Anger across diverse clinical samples. J Clin Epidemiol. 2016 May;73:119-27. doi: 10.1016/j.jclinepi.2015.08.036. Epub 2016 Feb 27.

    PubMed 26931289
  • Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available.

    PubMed 6668417
  • Teresi JA, Ocepek-Welikson K, Kleinman M, Ramirez M, Kim G. Psychometric Properties and Performance of the Patient Reported Outcomes Measurement Information System(R) (PROMIS(R)) Depression Short Forms in Ethnically Diverse Groups. Psychol Test Assess Model. 2016;58(1):141-181.

    PubMed 28553573
  • Clover K, Lambert SD, Oldmeadow C, Britton B, Mitchell AJ, Carter G, King MT. Convergent and criterion validity of PROMIS anxiety measures relative to six legacy measures and a structured diagnostic interview for anxiety in cancer patients. J Patient Rep Outcomes. 2022 Jul 20;6(1):80. doi: 10.1186/s41687-022-00477-4.

    PubMed 35857151
  • Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70. doi: 10.1037//0022-3514.54.6.1063.

    PubMed 3397865
  • Reniers RL, Corcoran R, Drake R, Shryane NM, Vollm BA. The QCAE: a Questionnaire of Cognitive and Affective Empathy. J Pers Assess. 2011 Jan;93(1):84-95. doi: 10.1080/00223891.2010.528484.

    PubMed 21184334

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Brief online writing intervention in people with Parent-Child Relations, run by Yale University at 4 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in United States, Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Parents' Rejecting and Supportive Behaviors Measured By the Parent Non-Acceptance Scale (time frame: Baseline, 5 Days Post-Baseline, and 3 Months Post-Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05919849, which also lists 17 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in